Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin (PEGASUS)

This study has been completed.
Information provided by (Responsible Party):
AstraZeneca Identifier:
First received: July 9, 2010
Last updated: December 22, 2014
Last verified: September 2014